INMUNE BIO INC's ticker is INMB and the CUSIP is 45782T105.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $383,888 | +146.0% | 56,702 | +130.4% | 0.11% | +134.8% |
| Q4 2022 | $156,035 | +3.3% | 24,611 | +1.2% | 0.05% | -6.1% |
| Q3 2022 | $151,000 | -28.8% | 24,311 | +1.2% | 0.05% | -33.8% |
| Q2 2022 | $212,000 | +28.5% | 24,011 | +22.6% | 0.07% | +19.4% |
| Q1 2022 | $165,000 | -9.8% | 19,586 | +9.1% | 0.06% | -7.5% |
| Q4 2021 | $183,000 | -26.5% | 17,955 | +39.9% | 0.07% | -39.1% |
| Q3 2021 | $249,000 | +20.9% | 12,830 | +9.2% | 0.11% | -8.3% |
| Q2 2021 | $206,000 | – | 11,750 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|